Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Incidence, risk factors, and health service burden of sequelae of Campylobacter and Non-typhoidal Salmonella infections in England, 2000-2015 : a retrospective cohort study using linked electronic health records Sequelae of gastrointestinal infections

Tools
- Tools
+ Tools

Esan, Oluwaseun B., Perera, Rafael, McCarthy, Noel D., Violato, Mara and Fanshawe, Thomas R. (2020) Incidence, risk factors, and health service burden of sequelae of Campylobacter and Non-typhoidal Salmonella infections in England, 2000-2015 : a retrospective cohort study using linked electronic health records Sequelae of gastrointestinal infections. Journal of Infection, 81 (2). pp. 221-230. doi:10.1016/j.jinf.2020.05.027 ISSN 0163-4453.

[img]
Preview
PDF
WRAP-incidence-risk-factors-health-service-burden-retrospective-cohort-health-McCarthy-2020.pdf - Accepted Version - Requires a PDF viewer.
Available under License Creative Commons Attribution Non-commercial No Derivatives 4.0.

Download (1153Kb) | Preview
Official URL: https://doi.org/10.1016/j.jinf.2020.05.027

Request Changes to record.

Abstract

Reactive arthritis, irritable bowel syndrome (IBS), Guillain-Barré syndrome, ulcerative colitis, and Crohn's disease may be sequelae of Campylobacter or non-typhoidal Salmonella (NTS) infections. Proton pump inhibitors (PPI) and antibiotics may increase the risk of gastrointestinal infections (GII); however, their impact on sequelae onset is unclear. We investigated the incidence of sequelae, their association with antibiotics and PPI prescription, and assessed the economic impact on the NHS.


Methods
Data from the Clinical Practice Research Datalink for patients consulting their GP for Campylobacter or NTS infection, during 2000-2015, were linked to hospital, mortality, and Index of Multiple Deprivation data. We estimated the incidence of sequelae and deaths in the 12 months following GII. We conducted logistic regression modelling for the adjusted association with prescriptions. We compared differences in resource use and costs pre- and post-infection amongst patients with and without sequelae.


Findings
Of 20,471 patients with GII (Campylobacter 17,838), less than 2% (347) developed sequelae, with IBS (268) most common. Among Campylobacter patients, those with prescriptions for PPI within 12 months before and cephalosporins within 7-days before/after infection had elevated risk of IBS (adjusted odds ratio [aOR] 2.1, 1.5-2.9) and (aOR 3.6, 1.1-11.7) respectively. Campylobacter sequelae lead to ∼ £1.3 million, (£750,000, £1.7 million) in additional annual NHS expenditure.


Interpretation
Sequelae of Campylobacter and NTS infections are rare but associated with increased NHS costs. Prior prescription of PPI may be a modifiable risk factor. Incidence of sequelae, healthcare resource use and costs are essential parameters for future burden of disease studies.

Item Type: Journal Article
Subjects: R Medicine > RB Pathology
R Medicine > RC Internal medicine
R Medicine > RM Therapeutics. Pharmacology
Divisions: Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School
SWORD Depositor: Library Publications Router
Library of Congress Subject Headings (LCSH): Diseases -- Complications , Gastrointestinal system -- Diseases , Proton pump inhibitors
Journal or Publication Title: Journal of Infection
Publisher: Elsevier
ISSN: 0163-4453
Official Date: 2 August 2020
Dates:
DateEvent
2 August 2020Published
20 May 2020Available
13 May 2020Accepted
Volume: 81
Number: 2
Page Range: pp. 221-230
DOI: 10.1016/j.jinf.2020.05.027
Status: Peer Reviewed
Publication Status: Published
Reuse Statement (publisher, data, author rights): ** Article version: AM ** From Elsevier via Jisc Publications Router ** History: accepted 13-05-2020; issue date 21-05-2020. ** Licence for AM version of this article starting on 18-05-2020: http://creativecommons.org/licenses/by-nc-nd/4.0/
Access rights to Published version: Open Access (Creative Commons)
Date of first compliant deposit: 12 June 2020
Date of first compliant Open Access: 12 June 2020
RIOXX Funder/Project Grant:
Project/Grant IDRIOXX Funder NameFunder ID
HP-RU-2002-10038[NIHR] National Institute for Health Researchhttp://dx.doi.org/10.13039/501100000272
UNSPECIFIEDPublic Health Englandhttp://dx.doi.org/10.13039/501100002141
UNSPECIFIEDUniversity of East Angliahttp://dx.doi.org/10.13039/501100000736
UNSPECIFIEDNuffield College, University of Oxfordhttp://dx.doi.org/10.13039/501100000666
Related URLs:
  • Publisher

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics

twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us